Topic: Regulatory Affairs

Manufacturing active pharmaceutical ingredients (APIs) is a complex undertaking that requires specialized process knowledge, advanced manufacturing capabilities, and…

In the highly competitive pharmaceutical industry, time to market plays a pivotal role in determining the success of…

Developing a peptide or oligonucleotide therapy requires more than scientific innovation, it demands a robust chemistry, manufacturing, and…

New drugs have to go through a long process of drug development before they reach the market. Along…

Bachem is a peptide and oligonucleotide manufacturer undergoing a steep growth curve together with our partners in pharmaceutical…

Regulatory authorities anticipate greater emphasis on analytical characterization at earlier stages of peptide therapeutics development. Let’s delve into recent…

ABOUT THE EVENT In its continuous efforts to facilitate and support the development and market authorization of complex…